Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanlengxiaoliu Mixture is a Traditional Chinese Medicine (TCM) herbal formulation developed by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily investigated as a maintenance therapy for patients with advanced gastric cancer who have achieved disease control after first-line chemotherapy. The formulation is based on TCM principles of "breaking blood and moving qi" to resolve masses, with *Sanleng* (*Sparganium stoloniferum*) as a key component. In clinical trials, it is evaluated for its ability to extend progression-free survival (PFS) and overall survival (OS) while improving the quality of life in an integrated medicine framework.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanlengxiaoliu Mixture.